Literature DB >> 21196417

Parent preferences for pediatric influenza vaccine attributes.

Emuella M Flood1, Kellie J Ryan, Matthew D Rousculp, Kathleen M Beusterien, Victoria M Divino, Stan L Block, Matthew C Hall, Parthiv J Mahadevia.   

Abstract

Influenza vaccine is available as an intramuscular injection or an intranasal spray for eligible children. This study was conducted to examine parents' preferences for influenza vaccine attributes and the attributes' relative importance regarding the vaccination of their children. A quantitative Web survey was administered to 500 parents of children aged 2 to 12 years. The survey included general preference questions and conjoint (trade-off) questions. Parents most frequently selected efficacy, risk of temporary side effects, and physician recommendation as important vaccine attributes from a provided list (92%, 75%, and 59%, respectively). For attributes selected as important, parents rated the importance of the attribute; the highest mean importance ratings were given to efficacy, presence of mercury-containing preservative, and physician recommendation.The highest relative importance ratings in the conjoint section were given to efficacy and presence of mercury-containing preservative. Parental education on influenza vaccine efficacy and safety may help to improve pediatric vaccination rates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21196417     DOI: 10.1177/0009922810391247

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  13 in total

Review 1.  Risk as an attribute in discrete choice experiments: a systematic review of the literature.

Authors:  Mark Harrison; Dan Rigby; Caroline Vass; Terry Flynn; Jordan Louviere; Katherine Payne
Journal:  Patient       Date:  2014       Impact factor: 3.883

2.  Acceptability of live attenuated influenza vaccine by vaccine providers in Quebec, Canada.

Authors:  Eve Dubé; Dominique Gagnon; Marilou Kiely; Nicole Boulianne; Monique Landry
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study.

Authors:  Jay V DePasse; Kenneth J Smith; Jonathan M Raviotta; Eunha Shim; Mary Patricia Nowalk; Richard K Zimmerman; Shawn T Brown
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

Review 4.  Individual Preferences for Child and Adolescent Vaccine Attributes: A Systematic Review of the Stated Preference Literature.

Authors:  Christine Michaels-Igbokwe; Shannon MacDonald; Gillian R Currie
Journal:  Patient       Date:  2017-12       Impact factor: 3.883

5.  Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.

Authors:  Jay V DePasse; Mary Patricia Nowalk; Kenneth J Smith; Jonathan M Raviotta; Eunha Shim; Richard K Zimmerman; Shawn T Brown
Journal:  Vaccine       Date:  2017-06-09       Impact factor: 3.641

6.  Identifying the impact of social influences in health-related discrete choice experiments.

Authors:  Esther W de Bekker-Grob; Kirsten Howard; Joffre Swait
Journal:  PLoS One       Date:  2022-10-19       Impact factor: 3.752

7.  Potential Consequences of Not Using Live Attenuated Influenza Vaccine.

Authors:  Kenneth J Smith; Mary Patricia Nowalk; Angela Wateska; Shawn T Brown; Jay V DePasse; Jonathan M Raviotta; Eunha Shim; Richard K Zimmerman
Journal:  Am J Prev Med       Date:  2017-04-18       Impact factor: 5.043

8.  Do parents prefer inactivated or live attenuated influenza vaccine for their children?

Authors:  Tammy A Santibanez; Katherine E Kahn; Carolyn B Bridges
Journal:  Vaccine       Date:  2018-10-16       Impact factor: 3.641

9.  Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.

Authors:  Frank Andersohn; Reinhard Bornemann; Oliver Damm; Martin Frank; Thomas Mittendorf; Ulrike Theidel
Journal:  GMS Health Technol Assess       Date:  2014-10-30

10.  Parents' and adolescents' willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay-Lac-St-Jean (Quebec).

Authors:  Eve Dubé; Dominique Gagnon; Denis Hamel; Sylvie Belley; Hélène Gagné; Nicole Boulianne; Monique Landry; Julie A Bettinger
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.